まとめ
発癌物質への曝露はハムスター細胞の細胞変異を誘発したが,ヒトの細胞は誘発しなかった,ハムスター細胞は変異率よりも高い変容率を示した. これらの変形した細胞は,後に腫瘍形成能力を発達させた.
科学分野:
- 細胞生物学 細胞生物学
- 発がん研究の研究は,がん発生に関する研究です.
- 毒理学 毒理学 毒理学
背景:
- 発がん物質に対する細胞反応を比較することは,がんの発症を理解する上で極めて重要です.
- 異なる種 (ヒトと中国ハムスター) の線維芽細胞系は,遺伝的および形態学的変化を研究するための明確なモデルを提供します.
- 変異と変容は,発癌物質によって引き起こされる細胞損傷の重要な指標です.
研究 の 目的:
- 発がん物質に曝されたヒトと中国ハムスターの線維芽細胞における自発的および誘発的変異および形態学的変異の頻度を比較する.
- 動物モデルにおける形態学的変容,アガー成長 (aga-),腫瘍形成の関係を調査する.
- 発がん性効果の評価において,異なる細胞システムの有用性を評価する.
主な方法:
- ヒトと中国ハムスターの原発性線維芽細胞は,発癌物質 (ベンゾ (α) ピレンとウレタン) で処理されました.
- 変異の頻度 (チオグアニン,オアバインに対する耐性,果糖の利用) と形態学的変異の頻度が測定されました.
- 変形細胞は,動物への注射後にアガーの成長 (再び) と腫瘍形成を評価した.
主要な成果:
- 変異頻度は,ヒトの細胞と中国ハムスターの細胞の両方で類似していました.
- 形態学的変異はハムスターの細胞のみで観察され,変異の頻度より約10^3倍高い頻度で発生しました.
- 形態学的に変化したハムスター細胞は,当初アガー陰性 (aga-) と非腫瘍原性であったが,変異イベントに似た速さでアガー陽性 (aga+) と腫瘍形成細胞へと移行することができた.
結論:
- 中国ハムスターの線維芽細胞は,ヒトの線維芽細胞よりも,発癌物質によって引き起こされる形態学的変化に敏感です.
- ハムスター細胞における形態学的変異は,より高い頻度で,点変異とは異なる細胞イベントを表しています.
- 変形したハムスター細胞の腫瘍発生性現象型への移行は,細胞因子によって調節できる多段階の癌発生過程を示唆しています.
関連する概念動画
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


